Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub Study

Clinical trial NCT00228514 · COMPLETED

Trial details

NCT number: NCT00228514
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rosuvastatin Heart Failure Positron Emission Tomography (PET)

Start date: 2004-02-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.